Octave Specialty Group (STU:FGPN) ROCE %: % (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:FGPN Octave Specialty Group Inc STU:FGPN
52 GF Score
Price €3.84
GF Value €5.95
Valuation Significantly Undervalued
View Full Analysis

What is Octave Specialty Group ROCE %?

Octave Specialty Group STU:FGPN +3.78% 52 ROCE % is % as of Jun. 2026. GuruFocus rates STU:FGPN with a GF Score™ of 52/100 and a GF Value™ of €5.95 (Significantly Undervalued).

ROCE % does not apply to banks and insurance companies.

STU:FGPN
52GF Score
Octave Specialty Group Inc STU:FGPN
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of % mean?
Octave Specialty Group (STU:FGPN) has a ROCE % of % as of Jun. 2026.
Is Octave Specialty Group's ROCE % too high?
Octave Specialty Group's current ROCE % is %. Overall, Octave Specialty Group has a GF Score™ of 52/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Octave Specialty Group's ROCE % compare to FACO and JRVR?
Octave Specialty Group's ROCE % of % can be compared against companies in the Insurance industry. The industry median ROCE % is 7.26. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for an Insurance company?
The median ROCE % among Insurance companies is 7.26, based on 62 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Insurance industry, the median ROCE % is 7.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Octave Specialty Group's current ROCE % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octave Specialty Group stock overvalued right now?
Based on GuruFocus' analysis, Octave Specialty Group (STU:FGPN) is currently considered Significantly Undervalued. The stock's GF Value™ is €5.95, compared to a current price of €3.84 — trading 35.5% below its estimated fair value. The current ROCE % is %. Octave Specialty Group's overall GF Score™ is 52/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Octave Specialty Group (STU:FGPN), the current ROCE % is % as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Octave Specialty Group (STU:FGPN) Overvalued in 2026?

Based on GuruFocus' analysis, Octave Specialty Group stock appears to be undervalued. The current stock price of €3.84 is trading 35.5% below its estimated GF Value™ of €5.95. GuruFocus considers Octave Specialty Group to be Significantly Undervalued.

Key valuation signals for STU:FGPN:

  • ROCE %: %
  • GF Value™: €5.95 vs. price of €3.84 (35.5% below fair value)
  • GF Score™: 52/100

No single metric tells the full story. See the STU:FGPN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Octave Specialty Group Business Description

Other Exchanges OSG:USA
Address 40 Wall Street, New York, NY, USA, 10005
Octave Specialty Group Inc is a world-wide specialty insurance firm that provides strategic direction, risk oversight, data and technology solutions, and capital support to MGA businesses operating across the U.S., U.K., and Bermuda. The company operates in two segments: Specialty Property and Casualty Insurance and ID.
52GF Score

Get the complete analysis for STU:FGPN

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.84
Price
€5.95
GF Value